AbbVie signs agreement and adds children’s AIDS drugs to shared patent pool

AbbVie,  a research-based bio pharmaceutical company from the US has signed a Licensing Agreement for HIV Paediatric Formulations of Lopinavir (LPV) and Ritonavir (r) with the Medicines Patent Pool (MPP) on World AIDS Day. The license agreement will enable others to re-formulate and manufacture specially designed LPV/r and r paediatric treatments for distribution in the developing world…